AALBERTS NV (AALB.AS)       45.53  +0.05 (+0.11%)

45.53  +0.05 (+0.11%)

NL0000852564 - Common Stock


Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to AALB. AALB was compared to 34 industry peers in the Machinery industry. While AALB has a great profitability rating, there are some minor concerns on its financial health. AALB is not valued too expensively and it also shows a decent growth rate.




Profitability

Profitability Rating

7

AALB's Return On Assets of 8.72% is amongst the best returns of the industry. AALB outperforms 95% of its industry peers. The industry average Return On Assets is 4.27%.
AALB's Return On Equity of 17.23% is amongst the best of the industry. AALB does better than the industry average Return On Equity of 11.13%.

AALB has a Profit Margin of 12.14%. This is amongst the best returns in the industry. The industry average is 5.33%. AALB outperforms 95% of its industry peers.
AALB has a Piotroski-F score of 5.00. This indicates an average health and profitability for AALB.
VS Industry

ROA (8.72%) VS Industry: 95% outperformed.

0.76
17.52

ROE (17.23%) VS Industry: 80% outperformed.

3.05
23.87

Profit Margin (12.14%) VS Industry: 95% outperformed.

1.20
15.82

Valuation

Valuation Rating

5

Compared to an average industry Price/Earning Ratio of 18.06, AALB is valued a bit cheaper than its industry peers.
The low PEG Ratio, which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
When comparing the Enterprise Value to EBITDA ratio of AALB to the average industry ratio of 9.15, AALB is valued rather cheaply.
With a Price/Earnings Ratio of 13.51, AALB is valued correctly.

The Forward Price/Earnings Ratio of 16.50 indicates a correct valuation of AALB.
When comparing the current price to the book value of AALB, we can conclude it is valued correctly. It is trading at 2.32 times its book value.
When comparing the price book ratio of AALB to the average industry price book ratio of 2.22, AALB is valued more expensive than its industry peers.
VS Industry

Price/Earnings (13.51) VS Industry: 68% outperformed.

50.00
6.24

Price/Book (2.32) VS Industry: 38% outperformed.

11.94
0.55

Enterprise Value/ EBITDA (7.61) VS Industry: 68% outperformed.

46.35
2.10

Growth

Growth Rating

5

The Earnings Per Share has grown by an impressive 87.03% over the past year.
AALB shows quite a strong growth in Earnings Per Share. Measured over the last 5 years, the EPS has been growing by 14.50% yearly.
When comparing the Revenue growth rate of the last 5 years to the growth rate of the upcoming 5 years, we see that the growth is accelerating.
AALB is expected to show a small growth in Earnings Per Share. In the coming 5 years, the EPS will grow by 8.36% yearly.

The Revenue has been growing slightly by 8.78% in the past year.
Measured over the past 5 years, AALB shows a small growth in Revenue. The Revenue has been growing by 3.39% on average per year.
AALB is expected to show a small growth in Revenue. In the coming 5 years, the Revenue will grow by 4.34% yearly.
When comparing the EPS growth rate of the last years to the growth rate of the upcoming 5 years, we see that the growth is decreasing.

PastFuture
5Y3Y1Y1Y2Y3Y5Y
EPS14.5% 14.69% 87.03% 15.54% 3.05% 7.12% 8.36%
Revenue3.39% 2.59% 8.78% 7.39% 2.86% 3.59% 4.34%

Health

Health Rating

6

When comparing the Debt to Equity Ratio of 0.30 to an average industry Debt to Equity of 0.51, AALB is way less dependent on financing that its industry peers.
AALB has an Altman-Z score of 3.30. This indicates that AALB is financially healthy and little risk of bankruptcy at the moment.
AALB has one of the better Altman-Z scores in its industry. It is much better than the industry average of 2.10. AALB has a better score than 82% of its industry peers.
AALB has a Current Ratio of 1.39. This is a normal value and indicates that AALB is financially healthy and should not expect problems in meeting its short term obligations.

The Current Ratio is in line with the industry averages, which is at 1.39.
AALB has a Piotroski-F score of 5.00. This indicates an average health and profitability for AALB.
A Quick Ratio of 0.67 indicates that AALB may have some problems paying its short term obligations.
When comparing the Quick Ratio of AALB to the average industry Current Ratio of 0.85, AALB is less able to pay its short term obligations than its industry peers.
VS Industry

Debt/Equity (0.3) VS Industry: 64% outperformed.

1.17
0.00

Quick Ratio (0.67) VS Industry: 21% outperformed.

0.43
13.26

Current Ratio (1.39) VS Industry: 51% outperformed.

0.50
14.82

Altman-Z (3.3) VS Industry: 82% outperformed.

-6.62
23.18

Dividend

Dividend Rating

6

AALB's Dividend Yield is rather good when compared to the industry average which is at 2.78. AALB pays more dividend than 88% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.41, AALB pays a better dividend.
On average, the dividend of AALB grows each year by 30.06%, which is quite nice.

AALB has a Yearly Dividend Yield of 3.90%.
The dividend of AALB is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
VS Industry

Dividend Yield (3.9%) VS Industry: 88% outperformed.

0.97
4.99

AALBERTS NV45.53

AMS:AALB (2/3/2023, 7:00:00 PM)+0.05 (+0.11%)

Chartmill FA Rating
GICS Sector Industrials
GICS IndustryGroup Capital Goods
GICS Industry Machinery
Earnings (Last) N/A N/A Earnings (Next) N/A N/A
Inst Owners N/A Inst Owner Change N/A
Ins Owners N/A Ins Owner Change N/A
Market Cap 5.03B Analysts 81.54
Price Target 51.15 (12.34%)

Dividend
Industry RankSector Rank
Dividend Yield 3.9%
Dividend Growth(5Y) 30.06% DP N/A
Div Incr Years N/A Div Non Decr Years N/A
Ex-Date N/A

Surprises & Revisions
EPS beat(2) 1 Avg EPS beat(2) 13.59%
Min EPS beat(2) 13.59% Max EPS beat(2) 13.59%
EPS beat(4) 2 Avg EPS beat(4) 10.4%
Min EPS beat(4) 7.21% Max EPS beat(4) 13.59%
Revenue beat(2) N/A Avg Revenue beat(2) -1%
Min Revenue beat(2) -1% Max Revenue beat(2) -1%
Revenue beat(4) N/A Avg Revenue beat(4) -2.36%
Min Revenue beat(4) -3.72% Max Revenue beat(4) -1%
PT rev (1m) 1.64% PT rev (3m) 0.96%
EPS NQ rev (1m) N/A EPS NQ rev (3m) N/A
EPS NY rev (1m) 0% EPS NY rev (3m) -0.07%
Revenue NQ rev (1m) N/A Revenue NQ rev (3m) N/A
Revenue NY rev (1m) 0% Revenue NY rev (3m) 0.05%

Valuation
Industry RankSector Rank
PE 13.51
Fwd PE 16.5
P/S 1.63
P/FCF 171.25
P/OCF 23.1
P/B 2.32
P/tB 7.47
EV/EBITDA 7.61
EPS(TTM) 3.37 EY 7.4%
EPS(NY) 2.76 Fwd EY 6.06%
FCF(TTM) 0.27 FCFY 0.58%
OCF(TTM) 1.97 OCFY 4.33%
SpS 27.88 BVpS 19.64
TBVpS 6.09 PEG (NY) 0.87
PEG (5Y) 0.93

Profitability
Industry RankSector Rank
ROA 8.72%
ROE 17.23%
ROIC 12.24%
ROICexc 13.28%
ROICexgc 26.67%
OM 17.09%
PM 12.14%
GM 62.32%
ROICexgc(3y) 19.5% ROICexcg growth 3Y 7.84%
ROICexcg growth 5Y 10.98% ROICexc(3y) 9.64%
ROICexc growth 3Y 9.59% ROICexc growth 5Y 10.85%
OM growth 3Y 12.47% OM growth 5Y 11.45%
PM growth 3Y 11.87% PM growth 5Y 10.79%
GM growth 3Y -0.03% GM growth 5Y 0.15%
F-Score 5 Asset Turnover 0.72

Health
Industry RankSector Rank
Debt/Equity 0.3
Debt/FCF 30.84
Debt/EBITDA 1.24
Cap/Depr 93.64%
Profit Quality 7.86%
Current Ratio 1.39
Quick Ratio 0.67
Altman-Z 3.3
F-Score 5 WACC 7.19%
ROIC/WACC 3.71 Cap/Depr(3y) 77.1%
Cap/Depr(5y) 86.76% Profit Quality(3y) 118.77%
Profit Quality(5y) 107.96%

Growth
EPS 1Y 87.03% EPS 3Y 14.69%
EPS 5Y 14.5% EPS growth Q2Q 9.85%
EPS Next Y 15.54% EPS Next 2Y 3.05%
EPS Next 3Y 7.12% EPS Next 5Y 8.36%
Revenue growth 1Y 8.78% Revenue growth 3Y 2.59%
Revenue growth 5Y 3.39% Revenue growth Q2Q 6.88%
Revenue Next Year 7.39% Revenue Next 2Y 2.86%
Revenue Next 3Y 3.59% Revenue Next 5Y 4.34%
EBIT growth 1Y 81.25% EBIT growth 3Y 15.39%
EBIT growth 5Y 15.22% EBIT Next Year 50.65%
EBIT Next 3Y 17.1% EBIT Next 5Y N/A
FCF growth 1Y -87.59% FCF growth 3Y -10.11%
FCF growth 5Y -6.61% OCF growth 1Y -43.97%
OCF growth 3Y -3.22% OCF growth 5Y -0.92%

Fundamental Stock Screener Links

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the EuroNext

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the EuroNext

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the EuroNext

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the EuroNext